Autoriders International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 6, 2025, 11:12 pm

Competitors of Autoriders International Ltd

All Competitor Stocks of Autoriders International Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:55 pm

Below is a detailed analysis of the quarterly data for Autoriders International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 23.27 Cr.. The value appears to be declining and may need further review. It has decreased from 24.91 Cr. (Mar 2025) to 23.27 Cr., marking a decrease of 1.64 Cr..
• For Expenses, as of Jun 2025, the value is 17.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.91 Cr. (Mar 2025) to 17.11 Cr., marking an increase of 0.20 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.16 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 6.16 Cr., marking a decrease of 1.84 Cr..
• For OPM %, as of Jun 2025, the value is 26.47%. The value appears to be declining and may need further review. It has decreased from 32.12% (Mar 2025) to 26.47%, marking a decrease of 5.65%.
• For Other Income, as of Jun 2025, the value is 0.10 Cr.. The value appears to be declining and may need further review. It has decreased from 0.45 Cr. (Mar 2025) to 0.10 Cr., marking a decrease of 0.35 Cr..
• For Interest, as of Jun 2025, the value is 0.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.82 Cr. (Mar 2025) to 0.78 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 3.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 3.14 Cr., marking an increase of 0.14 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.34 Cr.. The value appears to be declining and may need further review. It has decreased from 4.63 Cr. (Mar 2025) to 2.34 Cr., marking a decrease of 2.29 Cr..
• For Tax %, as of Jun 2025, the value is 23.50%. The value appears to be improving (decreasing) as expected. It has decreased from 30.89% (Mar 2025) to 23.50%, marking a decrease of 7.39%.
• For Net Profit, as of Jun 2025, the value is 1.78 Cr.. The value appears to be declining and may need further review. It has decreased from 3.21 Cr. (Mar 2025) to 1.78 Cr., marking a decrease of 1.43 Cr..
• For EPS in Rs, as of Jun 2025, the value is 30.68. The value appears to be declining and may need further review. It has decreased from 55.34 (Mar 2025) to 30.68, marking a decrease of 24.66.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:51 am

Growth

Last Updated: September 5, 2025, 2:31 pm

Balance Sheet

Last Updated: October 10, 2025, 3:33 pm

Below is a detailed analysis of the balance sheet data for Autoriders International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 0.58 Cr.. The value appears strong and on an upward trend. It has increased from 0.49 Cr. (Mar 2024) to 0.58 Cr., marking an increase of 0.09 Cr..
• For Reserves, as of Mar 2025, the value is 48.95 Cr.. The value appears strong and on an upward trend. It has increased from 31.92 Cr. (Mar 2024) to 48.95 Cr., marking an increase of 17.03 Cr..
• For Borrowings, as of Mar 2025, the value is 32.16 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 28.50 Cr. (Mar 2024) to 32.16 Cr., marking an increase of 3.66 Cr..
• For Other Liabilities, as of Mar 2025, the value is 11.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.15 Cr. (Mar 2024) to 11.04 Cr., marking an increase of 0.89 Cr..
• For Total Liabilities, as of Mar 2025, the value is 92.73 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.06 Cr. (Mar 2024) to 92.73 Cr., marking an increase of 21.67 Cr..
• For Fixed Assets, as of Mar 2025, the value is 57.10 Cr.. The value appears strong and on an upward trend. It has increased from 44.59 Cr. (Mar 2024) to 57.10 Cr., marking an increase of 12.51 Cr..
• For CWIP, as of Mar 2025, the value is 3.33 Cr.. The value appears strong and on an upward trend. It has increased from 1.25 Cr. (Mar 2024) to 3.33 Cr., marking an increase of 2.08 Cr..
• For Investments, as of Mar 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.01 Cr..
• For Other Assets, as of Mar 2025, the value is 32.29 Cr.. The value appears strong and on an upward trend. It has increased from 25.21 Cr. (Mar 2024) to 32.29 Cr., marking an increase of 7.08 Cr..
• For Total Assets, as of Mar 2025, the value is 92.73 Cr.. The value appears strong and on an upward trend. It has increased from 71.06 Cr. (Mar 2024) to 92.73 Cr., marking an increase of 21.67 Cr..

Notably, the Reserves (48.95 Cr.) exceed the Borrowings (32.16 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Autoriders International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 140.83. This value is within the healthy range. It has decreased from 191.00 (Mar 24) to 140.83, marking a decrease of 50.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 140.83. This value is within the healthy range. It has decreased from 191.00 (Mar 24) to 140.83, marking a decrease of 50.17.
• For Cash EPS (Rs.), as of Mar 25, the value is 338.30. This value is within the healthy range. It has decreased from 400.61 (Mar 24) to 338.30, marking a decrease of 62.31.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 853.82. It has increased from 661.43 (Mar 24) to 853.82, marking an increase of 192.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 853.82. It has increased from 661.43 (Mar 24) to 853.82, marking an increase of 192.39.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 1.00, marking an increase of 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,500.99. It has decreased from 1,702.24 (Mar 24) to 1,500.99, marking a decrease of 201.25.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 437.56. This value is within the healthy range. It has decreased from 491.84 (Mar 24) to 437.56, marking a decrease of 54.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is 243.84. This value is within the healthy range. It has decreased from 283.88 (Mar 24) to 243.84, marking a decrease of 40.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 194.48. This value is within the healthy range. It has decreased from 226.33 (Mar 24) to 194.48, marking a decrease of 31.85.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 144.58. This value is within the healthy range. It has decreased from 192.65 (Mar 24) to 144.58, marking a decrease of 48.07.
• For PBDIT Margin (%), as of Mar 25, the value is 29.15. This value is within the healthy range. It has increased from 28.89 (Mar 24) to 29.15, marking an increase of 0.26.
• For PBIT Margin (%), as of Mar 25, the value is 16.24. This value is within the healthy range. It has decreased from 16.67 (Mar 24) to 16.24, marking a decrease of 0.43.
• For PBT Margin (%), as of Mar 25, the value is 12.95. This value is within the healthy range. It has decreased from 13.29 (Mar 24) to 12.95, marking a decrease of 0.34.
• For Net Profit Margin (%), as of Mar 25, the value is 9.63. This value is within the healthy range. It has decreased from 11.31 (Mar 24) to 9.63, marking a decrease of 1.68.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.93. This value is within the healthy range. It has decreased from 29.12 (Mar 24) to 16.93, marking a decrease of 12.19.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.53. This value is within the healthy range. It has decreased from 26.17 (Mar 24) to 19.53, marking a decrease of 6.64.
• For Return On Assets (%), as of Mar 25, the value is 9.04. This value is within the healthy range. It has decreased from 13.28 (Mar 24) to 9.04, marking a decrease of 4.24.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has decreased from 0.51 (Mar 24) to 0.37, marking a decrease of 0.14.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.64. This value is within the healthy range. It has decreased from 0.87 (Mar 24) to 0.64, marking a decrease of 0.23.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. It has decreased from 1.21 (Mar 24) to 1.06, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has increased from 1.11 (Mar 24) to 1.33, marking an increase of 0.22.
• For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 1.11 (Mar 24) to 1.33, marking an increase of 0.22.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.31 (Mar 24) to 0.00, marking a decrease of 0.31.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.15 (Mar 24) to 0.00, marking a decrease of 0.15.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.69 (Mar 24) to 0.00, marking a decrease of 99.69.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.85 (Mar 24) to 0.00, marking a decrease of 99.85.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.86. This value is within the healthy range. It has increased from 8.55 (Mar 24) to 8.86, marking an increase of 0.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 4.35 (Mar 24) to 3.93, marking a decrease of 0.42.
• For Enterprise Value (Cr.), as of Mar 25, the value is 44.24. It has increased from 26.72 (Mar 24) to 44.24, marking an increase of 17.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.32 (Mar 24) to 0.50, marking an increase of 0.18.
• For EV / EBITDA (X), as of Mar 25, the value is 1.74. This value is below the healthy minimum of 5. It has increased from 1.11 (Mar 24) to 1.74, marking an increase of 0.63.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.03 (Mar 24) to 0.23, marking an increase of 0.20.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.68 (Mar 24) to 0.00, marking a decrease of 99.68.
• For Price / BV (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.07 (Mar 24) to 0.40, marking an increase of 0.33.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.03 (Mar 24) to 0.23, marking an increase of 0.20.
• For EarningsYield, as of Mar 25, the value is 0.41. This value is below the healthy minimum of 5. It has decreased from 3.75 (Mar 24) to 0.41, marking a decrease of 3.34.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness